HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Samyang Holdings Corp.

www.samyang.com

Latest From Samyang Holdings Corp.

Asia Deal Watch: RAPT And Hanmi Partner On CCR4 Antagonist Offering Potential In Multiple Cancer Types

RAPT can earn up to $108m in milestones plus sales royalties under the deal. BerGenBio, Piramal partner on developing AML therapy.

Deals Business Strategies

Deals Shaping The Medical Industry, June 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type –Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device

Sorrento signs option for all-stock acquisition of Igdrasol run by developers of Abraxane

San Diego-based Sorrento Therapeutics signed an exclusive option to acquire Igdrasol, a private company in Fountain Valley, California that develops second-generation chemotherapy agents and is run by former Abraxis Bioscience employees involved in the creation of Celgene's blockbuster Abraxane.

Cancer Orthopedics

Takeda and Samyang take up RNAi drug delivery challenge

Takeda is tapping into the drug delivery expertise of South Korea's Samyang Corp to address one of the main obstacles facing the development of effective RNA interfering therapeutics.

Gastrointestinal Cancer
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • South Korea
  • Parent & Subsidiaries
  • Samyang Holdings Corp.
  • Senior Management
  • Yoon Kim, CEO
  • Contact Info
  • Samyang Holdings Corp.
    Phone: (82) 2 740 7111
    263 Yeonji-dong
    Jongno-gu
    Seoul, 110-725
    South Korea
UsernamePublicRestriction

Register